In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009.
about
Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosisNon-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosisBranched-chain amino acids for people with hepatic encephalopathyAcetyl-L-carnitine for patients with hepatic encephalopathyBranched-chain amino acids for people with hepatic encephalopathyEvaluation and Management of Hepatic Encephalopathy: Current Status and Future DirectionsAdvances in cirrhosis: Optimizing the management of hepatic encephalopathyManagement options in decompensated cirrhosisAntibiotics for the treatment of hepatic encephalopathyEvaluation of the impact of rehospitalization in the management of hepatic encephalopathyManagement of Hepatic Encephalopathy: A PrimerHepatic Encephalopathy: An Update on the Pathophysiology and Therapeutic Options.Management of hepatic encephalopathy in the hospitalProlonged remission from hepatic encephalopathy with rifaximin: results of a placebo crossover analysis.MELD score and antibiotics use are predictors of length of stay in patients hospitalized with hepatic encephalopathyCovert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalizationCognitive reserve is a determinant of health-related quality of life in patients with cirrhosis, independent of covert hepatic encephalopathy and model for end-stage liver disease score.The confusion assessment method for the intensive care unit in patients with cirrhosisOvert hepatic encephalopathy in Italy: clinical outcomes and healthcare costs.Declining liver graft quality threatens the future of liver transplantation in the United StatesEmergency department visits related to cirrhosis: a retrospective study of the nationwide emergency department sample 2006 to 2011.Covert and Overt Hepatic Encephalopathy: Diagnosis and ManagementCognitive dysfunction is associated with poor socioeconomic status in patients with cirrhosis: an international multicenter studyImpact of pretransplant hepatic encephalopathy on liver posttransplantation outcomes.Impact of ornithine phenylacetate (OCR-002) in lowering plasma ammonia after upper gastrointestinal bleeding in cirrhotic patientsNitrosative Stress-Induced Disruption of Baroreflex Neural Circuits in a Rat Model of Hepatic Encephalopathy: A DTI Study.Hepatic encephalopathy: effects of liver failure on brain function.Current diagnosis and management of post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy.Trends in Characteristics of Patients Listed for Liver Transplantation Will Lead to Higher Rates of Waitlist Removal Due to Clinical Deterioration.Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy.Recent developments in the diagnosis and treatment of covert/minimal hepatic encephalopathy.The patient buddy app can potentially prevent hepatic encephalopathy-related readmissions.Fecal Microbiota Transplant from a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial.Branched-chain amino acids for people with hepatic encephalopathy.Nonabsorbable disaccharides for hepatic encephalopathy: A systematic review and meta-analysis.Contemporary Understanding and Management of Overt and Covert Hepatic Encephalopathy.Probiotics for people with hepatic encephalopathy.Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy.The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin-α.The Impact of Redistricting Proposals on Health Care Expenditures for Liver Transplant Candidates and Recipients.
P2860
Q24185782-FF0698CA-0D74-4A19-B85A-69020ECA8738Q24185895-DFF76443-219F-4180-8FEE-299E228F4332Q24187134-B8C102E8-98F4-41C1-9482-E696EB9EA0E1Q24187553-CCD4EB02-1A18-42AC-937F-E389628A079CQ24187960-806DC355-0900-485C-A341-562659022C4CQ26744689-17023CAD-DA8B-43BE-ABB5-F897E6A07613Q26774018-F54270D2-8CDF-4841-91F3-F06060A68B34Q26800238-AEB2700C-4D8F-4184-9133-84C10D29B387Q27012878-1F79C368-F9F1-49CC-B978-C32A32217090Q28085014-BDA7AB31-46AC-4C50-86E1-A90F763ED776Q28275197-398C2E94-9E25-47A4-A605-2937102364BAQ33805285-8EEADDDE-C979-47F7-A86F-B678A42B3197Q34028149-23A33548-9A4F-4980-972C-AABD00597535Q34823693-8CFE11F3-3646-404A-838A-DFE04EAF6213Q34874260-DBD4AD1A-7BAD-40C3-8C71-D77EA14595A2Q35064105-76CD2A2E-0708-4417-8823-F11BFB6F82D6Q35498468-213C76A1-5CEB-4C04-BE21-D86DC8CBCDFAQ35822530-991F8F6F-A326-4FCD-BFD9-D47BFD075343Q35862181-68A3C618-2C5F-4460-B932-7BBF4EB80893Q36051195-93BA3A13-EE82-42CA-974A-2882B5E670F2Q36152842-E4921710-B468-4DDC-BFBC-8B2E73F18EE5Q36199772-353BC084-8134-445B-AE9E-229E6AE4B809Q37256639-01FC14E7-AC44-488B-9D90-692A172A12F4Q37353473-9EBD0F15-E9FD-4C59-B5F8-B5D5E73738CCQ37361451-61E95D6A-5F31-4052-A902-B0B1AC8D86E6Q37581557-AB58F6E8-8BEF-4B9B-9271-7CF8F242D73BQ38154754-39847324-9854-48FB-9947-C52B706CE483Q38579057-92481A81-7AE5-41B3-8EED-67C206D629BFQ38600187-CC68354C-DDF0-41A1-921F-9831C274AD6FQ38630676-C22CF0D4-B71F-4D32-A8BB-27B096766CB0Q38693964-ABE919F9-402B-4A40-8960-E524A58CD83EQ38724113-BBCFB875-4577-403D-BCC4-FBF2082B283CQ38740977-A42E915E-7E48-4DE2-B66F-E73F37D0C6F2Q38778053-46824BB3-5D89-4931-AF9D-C8169D932CCAQ38809023-A015D9E1-446B-4B2A-9840-0F32C88D5617Q38835093-E82C69DD-23F3-40C9-8A4C-EA9CBE9EF877Q38946102-59EFA6F4-7033-4FEE-8F61-1FF6485F9646Q39459234-2A6DE973-0039-47E0-917E-9E8ABD9AD03EQ39942156-6867985E-EC60-4AEB-9DC4-542A0C830AD2Q40095028-E17F1B24-1298-4BFE-8C91-76A61411BD46
P2860
In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
In-hospital mortality and econ ...... ited States from 2005 to 2009.
@en
type
label
In-hospital mortality and econ ...... ited States from 2005 to 2009.
@en
prefLabel
In-hospital mortality and econ ...... ited States from 2005 to 2009.
@en
P2093
P1476
In-hospital mortality and econ ...... ited States from 2005 to 2009.
@en
P2093
Alita Mishra
Chapy Venkatesan
Maria Stepanova
Zobair M Younossi
P304
1034-41.e1
P356
10.1016/J.CGH.2012.05.016
P407
P577
2012-05-27T00:00:00Z